Skip to main content
Erschienen in: Rheumatology International 7/2011

01.07.2011 | Review

Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis

verfasst von: Dae-Seog Lim, Yong-Soo Bae

Erschienen in: Rheumatology International | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

One of the varied characteristic features of the pathogenesis of rheumatoid arthritis (RA) is synovial hyperplasia. Fibroblast-like synoviocytes (FLSs) play a key role in the development of sustained inflammation in arthritic joints. We have reported previously that metastatic lymph node 51 (MLN51) is involved in the proliferation of FLSs in the pathogenesis of RA. Interestingly, the overexpression of MLN51 was observed only in RA FLSs, but not in osteoarthritis FLSs, possibly expecting that MLN51 may be a RA-specific marker. Additionally, we found that granulocyte–macrophage colony-stimulating factor signaling activates mitogen-activated protein kinase, followed by the upregulation of MLN51 and FLICE-inhibitory protein, resulting in FLS hyperplasia in RA. Based on these studies, we could be firm that MLN51 is a key factor in FLS hyperplasia of RA patients.
Literatur
1.
Zurück zum Zitat Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916PubMedCrossRef Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916PubMedCrossRef
2.
3.
Zurück zum Zitat Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041–1045PubMedCrossRef Saxne T, Palladino MA Jr, Heinegard D, Talal N, Wollheim FA (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31:1041–1045PubMedCrossRef
4.
Zurück zum Zitat Chikanza IC, Kingsley G, Panayi GS (1995) Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J Rheumatol 22:600–606PubMed Chikanza IC, Kingsley G, Panayi GS (1995) Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis. J Rheumatol 22:600–606PubMed
5.
Zurück zum Zitat Gitter BD, Labus JM, Lees SL, Scheetz ME (1989) Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology 66:196–200PubMed Gitter BD, Labus JM, Lees SL, Scheetz ME (1989) Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha. Immunology 66:196–200PubMed
6.
Zurück zum Zitat Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga M (1993) The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 94:145–149PubMedCrossRef Shingu M, Nagai Y, Isayama T, Naono T, Nobunaga M (1993) The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 94:145–149PubMedCrossRef
7.
Zurück zum Zitat Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593PubMedCrossRef Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593PubMedCrossRef
8.
Zurück zum Zitat Feldmann M (2001) Pathogenesis of arthritis: recent research progress. Nat Immunol 2:771–773PubMedCrossRef Feldmann M (2001) Pathogenesis of arthritis: recent research progress. Nat Immunol 2:771–773PubMedCrossRef
9.
Zurück zum Zitat Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343:1594–1602PubMedCrossRef Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343:1594–1602PubMedCrossRef
10.
Zurück zum Zitat van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JW (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39:829–835PubMedCrossRef van Roon JA, van Roy JL, Gmelig-Meyling FH, Lafeber FP, Bijlsma JW (1996) Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 39:829–835PubMedCrossRef
11.
Zurück zum Zitat Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N, Maruyama M, Kobayashi M (1995) Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 22:2020–2026PubMed Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hori T, Yamashita N, Maruyama M, Kobayashi M (1995) Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 22:2020–2026PubMed
12.
Zurück zum Zitat Smith RS, Smith TJ, Blieden TM, Phipps RP (1997) Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151:317–322PubMed Smith RS, Smith TJ, Blieden TM, Phipps RP (1997) Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151:317–322PubMed
13.
Zurück zum Zitat Pap T, Muller-Ladner U, Gay RE, Gay S (2000) Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2:361–367PubMedCrossRef Pap T, Muller-Ladner U, Gay RE, Gay S (2000) Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res 2:361–367PubMedCrossRef
14.
Zurück zum Zitat Paleolog EM, Miotla JM (1998) Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target. Angiogenesis 2:295–307PubMedCrossRef Paleolog EM, Miotla JM (1998) Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target. Angiogenesis 2:295–307PubMedCrossRef
15.
16.
Zurück zum Zitat Yoshihara Y, Yamada H (2007) Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. Clin Calcium 17:500–508PubMed Yoshihara Y, Yamada H (2007) Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis. Clin Calcium 17:500–508PubMed
17.
Zurück zum Zitat Obermajer N, Jevnikar Z, Doljak B, Kos J (2008) Role of cysteine cathepsins in matrix degradation and cell signalling. Connect Tissue Res 49:193–196PubMedCrossRef Obermajer N, Jevnikar Z, Doljak B, Kos J (2008) Role of cysteine cathepsins in matrix degradation and cell signalling. Connect Tissue Res 49:193–196PubMedCrossRef
18.
Zurück zum Zitat Kramer I, Wibulswas A, Croft D, Genot E (2003) Rheumatoid arthritis: targeting the proliferative fibroblasts. Prog Cell Cycle Res 5:59–70PubMed Kramer I, Wibulswas A, Croft D, Genot E (2003) Rheumatoid arthritis: targeting the proliferative fibroblasts. Prog Cell Cycle Res 5:59–70PubMed
19.
Zurück zum Zitat Degot S, Regnier CH, Wendling C, Chenard MP, Rio MC, Tomasetto C (2002) Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer. Oncogene 21:4422–4434PubMedCrossRef Degot S, Regnier CH, Wendling C, Chenard MP, Rio MC, Tomasetto C (2002) Metastatic Lymph Node 51, a novel nucleo-cytoplasmic protein overexpressed in breast cancer. Oncogene 21:4422–4434PubMedCrossRef
20.
Zurück zum Zitat Jang J, Lim DS, Choi YE, Jeong Y, Yoo SA, Kim WU, Bae YS (2006) MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 8:R170PubMedCrossRef Jang J, Lim DS, Choi YE, Jeong Y, Yoo SA, Kim WU, Bae YS (2006) MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 8:R170PubMedCrossRef
21.
Zurück zum Zitat Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H Jr, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W (2002) Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62:2625–2629PubMed Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H Jr, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W (2002) Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62:2625–2629PubMed
22.
Zurück zum Zitat Degot S, Le Hir H, Alpy F, Kedinger V, Stoll I, Wendling C, Seraphin B, Rio MC, Tomasetto C (2004) Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J Biol Chem 279:33702–33715PubMedCrossRef Degot S, Le Hir H, Alpy F, Kedinger V, Stoll I, Wendling C, Seraphin B, Rio MC, Tomasetto C (2004) Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module. J Biol Chem 279:33702–33715PubMedCrossRef
23.
Zurück zum Zitat Tange TO, Shibuya T, Jurica MS, Moore MJ (2005) Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. RNA 11:1869–1883PubMedCrossRef Tange TO, Shibuya T, Jurica MS, Moore MJ (2005) Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core. RNA 11:1869–1883PubMedCrossRef
24.
Zurück zum Zitat Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3:195–205PubMedCrossRef Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3:195–205PubMedCrossRef
25.
Zurück zum Zitat Wiegand HL, Lu S, Cullen BR (2003) Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc Natl Acad Sci U S A 100:11327–11332PubMedCrossRef Wiegand HL, Lu S, Cullen BR (2003) Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc Natl Acad Sci U S A 100:11327–11332PubMedCrossRef
26.
Zurück zum Zitat Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC (1995) Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11–q21.3 region of chromosome 17. Genomics 28:367–376PubMedCrossRef Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC (1995) Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11–q21.3 region of chromosome 17. Genomics 28:367–376PubMedCrossRef
27.
Zurück zum Zitat Ha JE, Choi YE, Jang J, Yoon CH, Kim HY, Bae YS (2008) FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. FEBS J 275:3546–3555PubMedCrossRef Ha JE, Choi YE, Jang J, Yoon CH, Kim HY, Bae YS (2008) FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. FEBS J 275:3546–3555PubMedCrossRef
28.
Zurück zum Zitat Yamanishi Y, Firestein GS (2001) Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 27:355–371PubMedCrossRef Yamanishi Y, Firestein GS (2001) Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 27:355–371PubMedCrossRef
29.
Zurück zum Zitat Ahn JH, Lee Y, Jeon C, Lee SJ, Lee BH, Choi KD, Bae YS (2002) Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 100:1742–1754PubMed Ahn JH, Lee Y, Jeon C, Lee SJ, Lee BH, Choi KD, Bae YS (2002) Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 100:1742–1754PubMed
30.
Zurück zum Zitat Goodall GJ, Bagley CJ, Vadas MA, Lopez AF (1993) A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 8:87–97PubMedCrossRef Goodall GJ, Bagley CJ, Vadas MA, Lopez AF (1993) A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 8:87–97PubMedCrossRef
31.
Zurück zum Zitat Trapnell BC, Whitsett JA (2002) Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775–802PubMedCrossRef Trapnell BC, Whitsett JA (2002) Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64:775–802PubMedCrossRef
32.
Zurück zum Zitat Gearing DP, King JA, Gough NM, Nicola NA (1989) Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 8:3667–3676PubMed Gearing DP, King JA, Gough NM, Nicola NA (1989) Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 8:3667–3676PubMed
33.
Zurück zum Zitat Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A (1990) Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci U S A 87:9655–9659PubMedCrossRef Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A (1990) Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci U S A 87:9655–9659PubMedCrossRef
34.
Zurück zum Zitat Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN (1994) JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335–4341PubMed Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin JD, Ihle JN (1994) JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335–4341PubMed
35.
Zurück zum Zitat Matsuguchi T, Zhao Y, Lilly MB, Kraft AS (1997) The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J Biol Chem 272:17450–17459PubMedCrossRef Matsuguchi T, Zhao Y, Lilly MB, Kraft AS (1997) The cytoplasmic domain of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha subunit is essential for both GM-CSF-mediated growth and differentiation. J Biol Chem 272:17450–17459PubMedCrossRef
36.
Zurück zum Zitat Duronio V, Clark-Lewis I, Federsppiel B, Wieler JS, Schrader JW (1992) Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. J Biol Chem 267:21856–21863PubMed Duronio V, Clark-Lewis I, Federsppiel B, Wieler JS, Schrader JW (1992) Tyrosine phosphorylation of receptor beta subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. J Biol Chem 267:21856–21863PubMed
37.
Zurück zum Zitat Sakamaki K, Miyajima I, Kitamura T, Miyajima A (1992) Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541–3549PubMed Sakamaki K, Miyajima I, Kitamura T, Miyajima A (1992) Critical cytoplasmic domains of the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541–3549PubMed
38.
Zurück zum Zitat Watanabe S, Itoh T, Arai K (1996) Roles of JAK kinases in human GM-CSF receptor signal transduction. J Allergy Clin Immunol 98:S183–S191PubMedCrossRef Watanabe S, Itoh T, Arai K (1996) Roles of JAK kinases in human GM-CSF receptor signal transduction. J Allergy Clin Immunol 98:S183–S191PubMedCrossRef
39.
Zurück zum Zitat Hackenmiller R, Kim J, Feldman RA, Simon MC (2000) Abnormal stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice. Immunity 13:397–407PubMedCrossRef Hackenmiller R, Kim J, Feldman RA, Simon MC (2000) Abnormal stat activation, hematopoietic homeostasis, and innate immunity in c-fes-/- mice. Immunity 13:397–407PubMedCrossRef
40.
Zurück zum Zitat Inoue T, Hammaker D, Boyle DL, Firestein GS (2005) Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J Immunol 174:4301–4306PubMed Inoue T, Hammaker D, Boyle DL, Firestein GS (2005) Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes. J Immunol 174:4301–4306PubMed
41.
Zurück zum Zitat Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G (2000) Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 43:2501–2512PubMedCrossRef Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G (2000) Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum 43:2501–2512PubMedCrossRef
42.
Zurück zum Zitat Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein GS (1998) Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152:1091–1098PubMed Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein GS (1998) Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152:1091–1098PubMed
43.
Zurück zum Zitat Lories RJ, Derese I, Ceuppens JL, Luyten FP (2003) Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48:2807–2818PubMedCrossRef Lories RJ, Derese I, Ceuppens JL, Luyten FP (2003) Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum 48:2807–2818PubMedCrossRef
44.
Zurück zum Zitat Palao G, Santiago B, Galindo M, Paya M, Ramirez JC, Pablos JL (2004) Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum 50:2803–2810PubMedCrossRef Palao G, Santiago B, Galindo M, Paya M, Ramirez JC, Pablos JL (2004) Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum 50:2803–2810PubMedCrossRef
45.
Zurück zum Zitat Safa AR, Day TW, Wu CH (2008) Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 8:37–46PubMedCrossRef Safa AR, Day TW, Wu CH (2008) Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 8:37–46PubMedCrossRef
47.
Zurück zum Zitat Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10:640–648PubMedCrossRef Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10:640–648PubMedCrossRef
48.
Zurück zum Zitat Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L (2000) Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19:4451–4460PubMedCrossRef Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L (2000) Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19:4451–4460PubMedCrossRef
49.
Zurück zum Zitat Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, Kinoshita T, Suda T (2004) Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279:46415–46423PubMedCrossRef Imamura R, Konaka K, Matsumoto N, Hasegawa M, Fukui M, Mukaida N, Kinoshita T, Suda T (2004) Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279:46415–46423PubMedCrossRef
50.
Zurück zum Zitat Miyazawa K, Mori A, Okudaira H (1998) Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem 124:1153–1162PubMed Miyazawa K, Mori A, Okudaira H (1998) Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. J Biochem 124:1153–1162PubMed
Metadaten
Titel
Metastatic lymph node 51 and fibroblast-like synoviocyte hyperproliferation in rheumatoid arthritis pathogenesis
verfasst von
Dae-Seog Lim
Yong-Soo Bae
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 7/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1818-x

Weitere Artikel der Ausgabe 7/2011

Rheumatology International 7/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.